Peter P. De Deyn

4.4k total citations
36 papers, 1.7k citations indexed

About

Peter P. De Deyn is a scholar working on Neurology, Physiology and Genetics. According to data from OpenAlex, Peter P. De Deyn has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 9 papers in Physiology and 8 papers in Genetics. Recurrent topics in Peter P. De Deyn's work include Amyotrophic Lateral Sclerosis Research (17 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Peter P. De Deyn is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (17 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Peter P. De Deyn collaborates with scholars based in Belgium, Netherlands and Germany. Peter P. De Deyn's co-authors include Christine Van Broeckhoven, Sebastiaan Engelborghs, Marc Cruts, Maria Mattheijssens, Karin Peeters, Julie van der Zee, Kristel Sleegers, Rik Vandenberghe, Ilse Gijselinck and Tim Van Langenhove and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Peter P. De Deyn

34 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter P. De Deyn Belgium 21 952 618 480 470 305 36 1.7k
Christine Sato Canada 28 1.0k 1.1× 943 1.5× 936 1.9× 437 0.9× 304 1.0× 66 2.3k
Gina Bisceglio United States 17 503 0.5× 813 1.3× 602 1.3× 253 0.5× 100 0.3× 25 1.5k
Miryam Carecchio Italy 24 749 0.8× 365 0.6× 499 1.0× 324 0.7× 73 0.2× 78 1.6k
Masamitsu Takatama Japan 18 722 0.8× 402 0.7× 364 0.8× 256 0.5× 200 0.7× 75 1.3k
Alida Spalloni Italy 19 800 0.8× 204 0.3× 404 0.8× 191 0.4× 371 1.2× 34 1.4k
Alessandro Simonati Italy 28 279 0.3× 864 1.4× 959 2.0× 223 0.5× 129 0.4× 94 2.2k
Tomokazu Obi Japan 16 740 0.8× 325 0.5× 538 1.1× 251 0.5× 159 0.5× 38 1.2k
Oriol Dols‐Icardo Spain 16 564 0.6× 700 1.1× 323 0.7× 335 0.7× 97 0.3× 40 1.2k
Jonathan Janssens Belgium 14 965 1.0× 339 0.5× 629 1.3× 164 0.3× 523 1.7× 20 1.7k
Yumiko Motoi Japan 26 762 0.8× 625 1.0× 451 0.9× 272 0.6× 33 0.1× 76 1.9k

Countries citing papers authored by Peter P. De Deyn

Since Specialization
Citations

This map shows the geographic impact of Peter P. De Deyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. De Deyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. De Deyn more than expected).

Fields of papers citing papers by Peter P. De Deyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. De Deyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. De Deyn. The network helps show where Peter P. De Deyn may publish in the future.

Co-authorship network of co-authors of Peter P. De Deyn

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. De Deyn. A scholar is included among the top collaborators of Peter P. De Deyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. De Deyn. Peter P. De Deyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mondragón, Jaime D., Bruno Lima Giacobbo, P. H. Elsinga, et al.. (2025). Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration. Nuclear Medicine and Biology. 152-153. 109581–109581.
2.
Dillen, Lubina, Sara Van Mossevelde, Jan De Bleecker, et al.. (2020). No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriers. Neurobiology of Aging. 97. 145.e1–145.e4. 1 indexed citations
3.
Philtjens, Stéphanie, Sara Van Mossevelde, Julie van der Zee, et al.. (2016). Unraveling the genetic role of SORT1 in the Belgian frontotemporal dementia population. Journal of Neurochemistry. 138. 310–311. 1 indexed citations
4.
Cuyvers, Elise, Karolien Bettens, Stéphanie Philtjens, et al.. (2013). Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiology of Aging. 35(3). 726.e11–726.e19. 148 indexed citations
5.
Claus, Rainer, Oliver Mücke, Kristin Rentzsch, et al.. (2013). Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathologica Communications. 1(1). 16–16. 35 indexed citations
6.
Dillen, Lubina, Tim Van Langenhove, Sebastiaan Engelborghs, et al.. (2013). Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiology of Aging. 34(6). 1711.e1–1711.e5. 31 indexed citations
7.
Cacace, Rita, Caroline Van Cauwenberghe, Karolien Bettens, et al.. (2013). C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 34(6). 1712.e1–1712.e7. 62 indexed citations
8.
Wils, Hans, Gernot Kleinberger, Sandra Pereson, et al.. (2012). Cellular ageing, increased mortality and FTLD‐TDP‐associated neuropathology in progranulin knockout mice. The Journal of Pathology. 228(1). 67–76. 94 indexed citations
9.
Zee, Julie van der, Tim Van Langenhove, Gernot Kleinberger, et al.. (2011). TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain. 134(3). 808–815. 94 indexed citations
10.
Langenhove, Tim Van, Julie van der Zee, Sebastiaan Engelborghs, et al.. (2011). Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiology of Aging. 33(5). 1004.e17–1004.e20. 31 indexed citations
11.
Sleegers, Kristel, Nathalie Brouwers, Philip Van Damme, et al.. (2009). Serum biomarker for progranulin‐associated frontotemporal lobar degeneration. Annals of Neurology. 65(5). 603–609. 160 indexed citations
12.
Gijselinck, Ilse, Kristel Sleegers, Sebastiaan Engelborghs, et al.. (2008). Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiology of Aging. 30(8). 1329–1331. 72 indexed citations
13.
Gijselinck, Ilse, Kristel Sleegers, Sebastiaan Engelborghs, et al.. (2007). Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Ghent University Academic Bibliography (Ghent University). 3 indexed citations
14.
Gijselinck, Ilse, Julie van der Zee, Sebastiaan Engelborghs, et al.. (2007). Progranulin locus deletion in frontotemporal dementia. Human Mutation. 29(1). 53–58. 73 indexed citations
15.
Mariën, Peter, Sebastiaan Engelborghs, Rudi D’Hooge, & Peter P. De Deyn. (2001). Familial sinistrality in crossed aphasia: A new case and review of the available literature. Aphasiology. 15(12). 1143–1168. 1 indexed citations
16.
D’Hooge, Rudi, et al.. (1999). Effects of competitive NMDA receptor antagonists on excitatory amino acid‐evoked currents in mouse spinal cord neurones. Fundamental and Clinical Pharmacology. 13(1). 67–74. 4 indexed citations
17.
Engelborghs, Sebastiaan, et al.. (1997). A patient with complex partial frontal lobe seizures as complication of bifrontal lobotomy. Epilepsia. 38. 194–194. 6 indexed citations
18.
Kooy, R. Frank, Rudi D’Hooge, Edwin Reyniers, et al.. (1996). Transgenic mouse model for the fragile X syndrome. American Journal of Medical Genetics. 64(2). 241–245. 141 indexed citations
19.
Marescau, Bart, Peter P. De Deyn, Ijaz A. Qureshi, et al.. (1992). The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid. Metabolism. 41(9). 1021–1024. 20 indexed citations
20.
Marescau, Bart, et al.. (1992). Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism. 41(5). 526–532. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Sato Breakdown of academic impact, for papers by Gina Bisceglio Breakdown of academic impact, for papers by Miryam Carecchio Breakdown of academic impact, for papers by Masamitsu Takatama Breakdown of academic impact, for papers by Alida Spalloni Breakdown of academic impact, for papers by Alessandro Simonati Breakdown of academic impact, for papers by Tomokazu Obi Breakdown of academic impact, for papers by Oriol Dols‐Icardo Breakdown of academic impact, for papers by Jonathan Janssens Breakdown of academic impact, for papers by Yumiko Motoi
Rankless by CCL
2026